NCT04944030View on ClinicalTrials.gov

Clinico-biological Data Collection Study of Metastatic Lung Cancer

NAActive, not recruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

April 12, 2023

Primary Completion Date

October 31, 2031

Study Completion Date

October 31, 2031

Conditions
Lung Cancer
Interventions
PROCEDURE

Metastasis biopsy

Metastasis biopsy will be performed for multi-omic analysis Biological/Vaccine: Biomarkers blood, urine and microbiota samples Biomarkers blood, urine and microbiota samples for multi-omic analysis Behavioral: Patient Reported Outcome (PRO) Patient Reported Outcome (PRO) will be collected throughout the study duration to assess quality of life, anxiety, depression distress, physical activity and food habits.

Trial Locations (2)

44805

Institut de Cancerologie de L'Ouest, Saint-Herblain

49933

Institut de Cancerologie de L'Ouest, Angers

All Listed Sponsors
lead

Institut Cancerologie de l'Ouest

OTHER